SANA BIOTECHNOLOGY INC (SANA) Stock Cash Flow
NASDAQ:SANA - Nasdaq - US7995661045 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -266.76M | -283.25M | -269.48M | -355.93M | -285.31M | |||
| Depreciation Amortization | 17.39M | 24.56M | 15.63M | 11.07M | 5.92M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Change In Working Capital | -1.19M | 18.61M | 7.54M | 9.80M | 6.16M | |||
| Other non cash items | 27.40M | -13.49M | -43.74M | 84.00M | 135.25M | |||
| OPERATING CASH FLOW | -223.15M | -253.58M | -290.05M | -251.05M | -137.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -33.43M | -20.03M | -20.88M | -29.86M | -23.87M | |||
| Other Investing Activity | 50.88M | 192.04M | 231.44M | -215.94M | -228.69M | |||
| INVESTING CASH FLOW | 17.45M | 172.01M | 210.56M | -245.80M | -252.56M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 192.00M | 31.65M | 4.91M | 631.75M | 435.69M | |||
| Other Financing Activity | 7.74M | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 199.75M | 31.65M | 4.91M | 631.75M | 435.69M | |||
| CHANGE IN CASH | -5.95M | -49.92M | -74.58M | 134.90M | 45.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -223.15M | -253.58M | -290.05M | -251.05M | -137.98M | |||
| Capital Expenditure | -33.43M | -20.03M | -20.88M | -29.86M | -23.87M | |||
| FREE CASH FLOW | -256.58M | -273.61M | -310.93M | -280.91M | -161.85M | |||
All data in USD